ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dyke, C. M.
Right arrow Articles by Salter, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dyke, C. M.
Right arrow Articles by Salter, D. R.

The Annals of Thoracic Surgery, Vol 56, 215-222, Copyright © 1993 by The Society of Thoracic Surgeons


ARTICLES

Effects of triiodothyronine supplementation after myocardial ischemia

CM Dyke, M Ding, AS Abd-Elfattah, K Loesser, RJ Dignan, AS Wechsler and DR Salter
Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.

Cardiopulmonary bypass causes a "euthyroid-sick" state characterized by low levels of circulating triiodothyronine. Triiodothyronine supplementation in this setting has been postulated to improve postischemic left ventricular function by increasing the availability of myocardial high-energy phosphates. These postulates have not been substantiated, however, using load-independent parameters of left ventricular function and analysis of high-energy phosphate metabolism. To test these hypotheses, 14 healthy pigs (30 to 40 kg) were placed on cardiopulmonary bypass and instrumented with left ventricular minor- axis ultrasonic crystals and micromanometer-tipped pressure catheters. Hearts were subjected to 30 minutes of global, normothermic ischemia. Triiodothyronine (0.1 mg/kg; n = 7) or placebo (n = 7) was administered in a random, investigator-blinded fashion at the removal of the aortic cross-clamp and after 60 minutes of reperfusion. Hemodynamic, metabolic, and ultrastructural data were obtained before ischemia and after 30, 60, 90, and 120 minutes of reperfusion. By 90 minutes of reperfusion left ventricular contractility had returned to preischemic levels in hearts supplemented with triiodothyronine, despite postischemic myocardial adenosine triphosphate levels of 50% to 60% of baseline in both groups. Ultrastructurally, the sarcoplasmic reticulum and mitochondria were significantly better preserved in the group treated with triiodothyronine. This study suggests that triiodothyronine supplementation significantly enhances postischemic left ventricular functional recovery and that this recovery is due to mechanisms other than enhanced availability of myocardial high-energy phosphates.


This article has been cited by other articles:


Home page
Card Surg AdultHome page
R. Salenger, J. S. Gammie, and T. J. Vander Salm
Postoperative Care of Cardiac Surgical Patients
Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469.
[Full Text]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. Guden, B. Akpinar, E. Saggbas, I. Sanisoglu, E. Cakali, and O. Bayindir
Effects of Intravenous Triiodothyronine During Coronary Artery Bypass Surgery
Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 219 - 222.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
N. Murai, Y. Katayama, T. Yamada, T. Imazeki, Y. Irie, H. Kiyama, Y. Sato, I. Hata, H. Yoshida, and M. Mukouyama
Thyroid Hormone and Myocardial Metabolism After Heart Surgery in Dogs
Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. D. Klemperer, I. L. Klein, K. Ojamaa, R. E. Helm, M. Gomez, O. W. Isom, and K. H. Krieger
Triiodothyronine Therapy Lowers the Incidence of Atrial Fibrillation After Cardiac Operations
Ann. Thorac. Surg., May 1, 1996; 61(5): 1323 - 1327.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale
THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action
J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Klemperer, J. Zelano, R. E. Helm, K. Berman, K. Ojamaa, I. Klein, O. W. Isom, and K. Krieger
Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia
J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 457 - 465.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.